Verrica Pharmaceuticals Inc. (VRCA) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Verica (VRCA) Q1 2026: YCANTH Applicator Units Jump 51% as Prescriber Base Expands
June 17, 2026
-
Verica Pharmaceuticals (VRCA) Q2 2025: Ycanth Applicator Units Jump 33%, Non-Dilutive Capital Bolsters Pipeline
June 16, 2026
-
Verica Pharmaceuticals (VRCA) Q3 2025: YCAMP Dispensed Units Up 33% as Focused Commercial Model Drives Expansion
June 16, 2026
-
Verica Pharmaceuticals (VRCA) Q4 2025: YCANTH Revenue Doubles, Margin Expands to 85.7% as Pipeline Advances
June 15, 2026